CONTEXT: Commercial announcement relating to decentralised clinical trial capabilities
IMPACT: Low
READ TIME: 1 min
1. “SCOTTSDALE, Ariz., March 9, 2021 /PRNewswire/ — VirTrial, the leading provider of telemedicine technology, and uMotif, the patient-centric data capture platform provider, are joining forces to combine their Decentralized Clinical Trial (DCT) technologies in one seamlessly integrated solution.”
2. “”By integrating the user-friendly data capture capabilities of the uMotif platform with the hybrid DCT capabilities of VirTrial’s telemedicine platform, customers can recruit and retain a large and diverse patient population for their studies, even while some sites are closed for in-person visits,” said Amanda Rangel, Executive VP of Virtual Trial Solutions at VirTrial.”
3. “”We value uMotif’s expertise in the clinical research industry and their approach to creating a patient-centric platform design that encourages use and secures critical trial data.””
4. “The addition of VirTrial’s video functionality and its easy-to-use interface aligns with our focus on patient-centricity,” said Bruce Hellman, CEO of uMotif, “The global pandemic has created high demand for remote data capture and virtual patient consultations, and we are seeing more of our customers adopt a decentralized model to ensure trials continue to operate.””
5. “About VirTrial. VirTrial, a Signant Health company, enables pharmaceutical companies and CROs to empower their preferred clinical research sites to perform virtual visits through– a combination of secure video, audio, chat, and messaging, which can be used on any device.”